BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17593158)

  • 1. Medical therapy and birth outcomes in women with Crohn's disease: what should we tell our patients?
    Friedman S
    Am J Gastroenterol; 2007 Jul; 102(7):1414-6. PubMed ID: 17593158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.
    Nørgård B; Pedersen L; Christensen LA; Sørensen HT
    Am J Gastroenterol; 2007 Jul; 102(7):1406-13. PubMed ID: 17437503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy and breastfeeding in patients with Crohn's disease.
    Mottet C; Juillerat P; Pittet V; Gonvers JJ; Froehlich F; Vader JP; Michetti P; Felley C
    Digestion; 2007; 76(2):149-60. PubMed ID: 18239407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome.
    Baiocco PJ; Korelitz BI
    J Clin Gastroenterol; 1984 Jun; 6(3):211-6. PubMed ID: 6144706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes.
    Reddy D; Murphy SJ; Kane SV; Present DH; Kornbluth AA
    Am J Gastroenterol; 2008 May; 103(5):1203-9. PubMed ID: 18422816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy and Crohn's disease.
    Mottet C; Juillerat P; Gonvers JJ; Froehlich F; Burnand B; Vader JP; Michetti P; Felley C
    Digestion; 2005; 71(1):54-61. PubMed ID: 15711051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study.
    Langagergaard V; Pedersen L; Gislum M; Nørgard B; Sørensen HT
    Aliment Pharmacol Ther; 2007 Jan; 25(1):73-81. PubMed ID: 17229222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of inflammatory bowel diseases during pregnancy.
    Dignass AU; Hartmann F; Sturm A; Stein J
    Dig Dis; 2009; 27(3):341-6. PubMed ID: 19786762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease activity in pregnant women with Crohn's disease and birth outcomes: a regional Danish cohort study.
    Nørgård B; Hundborg HH; Jacobsen BA; Nielsen GL; Fonager K
    Am J Gastroenterol; 2007 Sep; 102(9):1947-54. PubMed ID: 17573787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early pregnancy azathioprine use and pregnancy outcomes.
    Cleary BJ; Källén B
    Birth Defects Res A Clin Mol Teratol; 2009 Jul; 85(7):647-54. PubMed ID: 19343728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of medical treatment, smoking and disease activity on pregnancy outcomes in Crohn's disease.
    Julsgaard M; Nørgaard M; Hvas CL; Grosen A; Hasseriis S; Christensen LA
    Scand J Gastroenterol; 2014 Mar; 49(3):302-8. PubMed ID: 24417179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries.
    Fonager K; Sørensen HT; Olsen J; Dahlerup JF; Rasmussen SN
    Am J Gastroenterol; 1998 Dec; 93(12):2426-30. PubMed ID: 9860403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory bowel disease: management issues during pregnancy.
    Ferrero S; Ragni N
    Arch Gynecol Obstet; 2004 Sep; 270(2):79-85. PubMed ID: 12721680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pregnancy outcome in inflammatory bowel diseases].
    Tennenbaum R; Marteau P; Elefant E; Rambaud JC; Modigliani R; Gendre JP; Cosnes J
    Gastroenterol Clin Biol; 1999 May; 23(5):464-9. PubMed ID: 10429848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease.
    Rajapakse RO; Korelitz BI; Zlatanic J; Baiocco PJ; Gleim GW
    Am J Gastroenterol; 2000 Mar; 95(3):684-8. PubMed ID: 10710057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis.
    Rahimi R; Nikfar S; Rezaie A; Abdollahi M
    Reprod Toxicol; 2008 Feb; 25(2):271-5. PubMed ID: 18242053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.
    Ban L; Tata LJ; Fiaschi L; Card T
    Gastroenterology; 2014 Jan; 146(1):76-84. PubMed ID: 24126096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study.
    Coelho J; Beaugerie L; Colombel JF; Hébuterne X; Lerebours E; Lémann M; Baumer P; Cosnes J; Bourreille A; Gendre JP; Seksik P; Blain A; Metman EH; Nisard A; Cadiot G; Veyrac M; Coffin B; Dray X; Carrat F; Marteau P;
    Gut; 2011 Feb; 60(2):198-203. PubMed ID: 21115547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.
    de Lima-Karagiannis A; Zelinkova-Detkova Z; van der Woude CJ
    Am J Gastroenterol; 2016 Sep; 111(9):1305-12. PubMed ID: 27349339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.